New real-world evidence.
Comparative effectiveness of ambulatory monitors for arrhythmia diagnosis (CAMELOT).
Compared with all other monitoring services, Zio XT was associated with:
Study design and methodology
The claims represent the coding that providers used to document the care they provided to their patients and the follow-up paths those same patients followed. The only claims included in the analysis were for patients who had not had previous cardiac monitoring, resulting in a balanced and comprehensive comparison of retest and healthcare resource utilization.
The study cohort of 287,789 diagnostic-naïve patients was derived from the full Medicare fee-for-service data set of 1,582,784.
The cohort included 287,789 patients.
- Reynolds et al. Comparative effectiveness of ambulatory monitors for arrhythmia diagnosis: A retrospective analysis of Medicare beneficiaries managed with ambulatory cardiac monitors between 2017 and 2019. Accepted for ACC.23 presentation, presented in New Orleans, LA.
- Data on file. iRhythm Technologies, 2023.
- Specified arrhythmias defined by Hierarchical Condition Categories (HCC) 96.